Aligos Therapeutics Inc
NASDAQ:ALGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
|
S
|
Singapore Airlines Ltd
OTC:SINGF
|
SG |
|
Oriental Land Co Ltd
F:OLL
|
JP |
|
T
|
Talkspace Inc
NASDAQ:TALK
|
US |
|
Shyft Group Inc
NASDAQ:SHYF
|
US |
|
N
|
NVR Inc
F:NVE
|
US |
|
Celyad Oncology SA
F:1C0
|
BE |
|
W
|
Whitbread PLC
OTC:WTBCF
|
UK |
|
Astra Otoparts Tbk PT
IDX:AUTO
|
ID |
|
M
|
Matichon PCL
SET:MATI
|
TH |
|
Carmila SA
PAR:CARM
|
FR |
|
B
|
Banpu Power PCL
SET:BPP
|
TH |
|
S
|
Starbucks Corp
F:SRB
|
US |
|
China Literature Ltd
HKEX:772
|
CN |
|
S
|
Swatch Group AG
BMV:UHRN
|
CH |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
G
|
Gold Fields Ltd
JSE:GFI
|
ZA |
|
E
|
EnBW Energie Baden Wuerttemberg AG
DUS:EBK
|
DE |
|
Mirait One Corp
F:5FO
|
JP |
|
L
|
Lynas Rare Earths Ltd
F:LYIC
|
MY |
|
S
|
Starbucks Corp
BMV:SBUX
|
US |
|
Panasonic Holdings Corp
TSE:6752
|
JP |
|
MFA Financial Inc
NYSE:MFA
|
US |
|
Credit Suisse Group AG
SIX:CSGN
|
CH |
Bankruptcy Probability
Aligos Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aligos Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
35.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
379.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aligos Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aligos Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
